Clinical Trial Update: A Multicenter Study of Intensive Concomitant Chemoradiotherapy With Filgrastim (GCSF) for Patients With Locoregionally Advanced Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 multicenter study evaluating intensive concomitant chemoradiotherapy with filgrastim for locoregionally advanced head and neck cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Filgrastim (filgrastim)

Snippet

Sponsor: University of Chicago | Conditions: Head and Neck | Phase 2 | Status: COMPLETED